{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:15:48Z","timestamp":1778822148583,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.therap.2026.04.003","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T15:58:50Z","timestamp":1776787130000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacit\u00e9 du c\u00e9l\u00e9coxib, du diclof\u00e9nac, de l\u2019\u00e9toricoxib, de l\u2019ibuprof\u00e8ne, du k\u00e9toprof\u00e8ne et du naprox\u00e8ne dans les lombalgies avec ou sans radiculalgie\u00a0: revue syst\u00e9matique et m\u00e9ta-analyse des essais comparatifs randomis\u00e9s"],"prefix":"10.1016","author":[{"given":"Paul","family":"Alfieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Landry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9my","family":"Boussageon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2026.04.003_bib0200","series-title":"Lombalgie","year":"2023"},{"key":"10.1016\/j.therap.2026.04.003_bib0205","series-title":"Prise en charge du patient pr\u00e9sentant une lombalgie commune","year":"2019"},{"key":"10.1016\/j.therap.2026.04.003_bib0210","series-title":"La lombalgie, un enjeu de sant\u00e9 publique","year":"2022"},{"key":"10.1016\/j.therap.2026.04.003_bib0215","series-title":"Lombalgie. Effets sur la sant\u00e9","year":"2018"},{"key":"10.1016\/j.therap.2026.04.003_bib0220","series-title":"Lombalgie. Statistique","year":"2026"},{"key":"10.1016\/j.therap.2026.04.003_bib0225","doi-asserted-by":"crossref","first-page":"514","DOI":"10.7326\/M16-2367","article-title":"Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians","volume":"166","author":"Qaseem","year":"2017","journal-title":"An Intern Med"},{"key":"10.1016\/j.therap.2026.04.003_bib0230","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s40122-024-00623-4","article-title":"Dexketoprofen trometamol and tramadol hydrochloride fixed-dose combination in moderate to severe acute low back pain: a phase IV, randomized, parallel group, placebo, active-controlled study (DANTE)","volume":"13","author":"Varrassi","year":"2024","journal-title":"Pain Ther"},{"key":"10.1016\/j.therap.2026.04.003_bib0235","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13063-022-06028-y","article-title":"OPAL: a randomised, placebo-controlled trial of opioid analgesia for the reduction of pain severity in people with acute spinal pain: a statistical analysis plan","volume":"23","author":"Jones","year":"2022","journal-title":"Trials"},{"key":"10.1016\/j.therap.2026.04.003_bib0240","first-page":"CD012087","article-title":"Non-steroidal anti-inflammatory drugs for chronic low back pain. Cochrane Back and Neck Group","volume":"2","author":"Enthoven","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.therap.2026.04.003_bib0245","first-page":"CD013581","article-title":"Non-steroidal anti-inflammatory drugs for acute low back pain. Cochrane Back and Neck Group","volume":"4","author":"Van Der Gaag","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.therap.2026.04.003_bib0250","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.therap.2022.10.008","article-title":"Project rebuild the evidence base (REB): a method to interpret randomised clinical trials and their meta-analysis to present solid benefit\u2013risk assessments to patients","volume":"78","author":"Boussageon","year":"2023","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2026.04.003_bib0255","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.therap.2026.04.003_bib0260","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(07)61686-9","article-title":"Assessment of diclofenac or spinal manipulative therapy, or both, in addition to recommended first-line treatment for acute low back pain: a randomised controlled trial","volume":"370","author":"Hancock","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.therap.2026.04.003_bib0265","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/BRS.0b013e318275d09c","article-title":"Spinal high-velocity low amplitude manipulation in acute nonspecific low back pain: a double-blinded randomized controlled trial in comparison with diclofenac and placebo","volume":"38","author":"von Heymann","year":"2013","journal-title":"Spine"},{"key":"10.1016\/j.therap.2026.04.003_bib0270","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.therap.2026.04.003_bib0275","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00007632-198303000-00004","article-title":"A study of the natural history of back pain. Part 1: development of a reliable and sensitive measure of disability in low back pain","volume":"8","author":"Roland","year":"1983","journal-title":"Spine"},{"key":"10.1016\/j.therap.2026.04.003_bib0280","series-title":"Cochrane handbook for systematic reviews of interventions","year":"2019"},{"key":"10.1016\/j.therap.2026.04.003_bib0285","series-title":"RevMan Calculator","year":"2025"},{"key":"10.1016\/j.therap.2026.04.003_bib0290","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12916-016-0775-3","article-title":"Pain relief that matters to patients: systematic review of empirical studies assessing the minimum clinically important difference in acute pain","volume":"15","author":"Olsen","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/j.therap.2026.04.003_bib0295","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/ard.41.2.129","article-title":"Naproxen sodium, diflunisal, and placebo in the treatment of chronic back pain","volume":"41","author":"Berry","year":"1982","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.therap.2026.04.003_bib0300","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1526-5900(03)00633-3","article-title":"Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disabilit: a randomized, placebo-controlled, 3-month trial","volume":"4","author":"Birbara","year":"2003","journal-title":"J Pain"},{"key":"10.1016\/j.therap.2026.04.003_bib0305","doi-asserted-by":"crossref","first-page":"375","DOI":"10.5414\/CPP41375","article-title":"Relief of acute low back pain with diclofenac-K 12.5\u00a0mg tablets: a flexible dose, ibuprofen 200\u00a0mg and placebo-controlled clinical trial","volume":"41","author":"Dreiser","year":"2003","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.therap.2026.04.003_bib0310","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1097\/j.pain.0000000000003280","article-title":"Efficacy of naproxen in patients with sciatica: multicenter, randomized, double-blind, placebo-controlled trial","volume":"165","author":"Gr\u00f8vle","year":"2024","journal-title":"Pain"},{"key":"10.1016\/j.therap.2026.04.003_bib0315","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1097\/j.pain.0000000000001267","article-title":"A randomised, placebo-controlled clinical trial with the \u221e2\/3\/5 subunit selective GABA positive allosteric modulator PF-06372865 in patients with chronic low back pain","volume":"159","author":"Gurrell","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.therap.2026.04.003_bib0320","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(07)61686-9","article-title":"Assessment of diclofenac or spinal manipulative therapy, or both, in addition to recommended first-line treatment for acute low back pain: a randomised controlled trial","volume":"370","author":"Hancock","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.therap.2026.04.003_bib0325","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.1742-1241.2009.02187.x","article-title":"Efficacy and safety of lornoxicam compared with placebo and diclofenac in acute sciatica\/lumbo-sciatica: an analysis from a randomised, double-blind, multicentre, parallel-group study","volume":"63","author":"Herrmann","year":"2009","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.therap.2026.04.003_bib0330","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.pain.2011.05.003","article-title":"Efficacy and safety of tanezumab in the treatment of chronic low back pain","volume":"152","author":"Katz","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.therap.2026.04.003_bib0335","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.pain.2013.03.006","article-title":"Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain","volume":"154","author":"Kivitz","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.therap.2026.04.003_bib0340","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.2147\/JPR.S217045","volume":"12","author":"Predel","year":"2019","journal-title":"J Pain Res"},{"key":"10.1016\/j.therap.2026.04.003_bib0345","first-page":"CD012382","article-title":"Non-steroidal anti-inflammatory drugs for sciatica","volume":"10","author":"Rasmussen-Barr","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.therap.2026.04.003_bib0350","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1136\/annrheumdis-2016-210597","article-title":"Non-steroidal anti-inflammatory drugs for spinal pain: a systematic review and meta-analysis","volume":"76","author":"Machado","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.therap.2026.04.003_bib0355","first-page":"CD013815","article-title":"Pharmacological treatments for low back pain in adults: an overview of Cochrane Reviews","volume":"4","author":"Cashin","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.therap.2026.04.003_bib0360","series-title":"Les anti-inflammatoires non st\u00e9ro\u00efdiens","year":"2024"},{"key":"10.1016\/j.therap.2026.04.003_bib0365","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","article-title":"Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials","volume":"382","author":"Bhala","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.therap.2026.04.003_bib0370","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/17512433.2018.1516143","article-title":"NSAID induced gastrointestinal damage and designing GI-sparing NSAIDs","volume":"11","author":"Garc\u00eda-Rayado","year":"2018","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.therap.2026.04.003_bib0375","series-title":"Diclof\u00e9nac (Voltar\u00e8ne\u00ae ou autre)\u00a0\u2013\u00a0un m\u00e9dicament \u00e0 \u00e9carter des soins","year":"2025"},{"key":"10.1016\/j.therap.2026.04.003_bib0380","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0140-6736(14)60805-9","article-title":"Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial","volume":"384","author":"Williams","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.therap.2026.04.003_bib0385","first-page":"CD012230","article-title":"Paracetamol for low back pain","author":"Saragiotto","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.therap.2026.04.003_bib0195","series-title":"Actualit\u00e9\u00a0\u2013\u00a0Antalgiques opio\u00efdes\u00a0: l\u2019ANSM publie un \u00e9tat de lieux de la consommation en France","year":"2019"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595726000600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595726000600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:53:20Z","timestamp":1778820800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595726000600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":39,"alternative-id":["S0040595726000600"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2026.04.003","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacit\u00e9 du c\u00e9l\u00e9coxib, du diclof\u00e9nac, de l\u2019\u00e9toricoxib, de l\u2019ibuprof\u00e8ne, du k\u00e9toprof\u00e8ne et du naprox\u00e8ne dans les lombalgies avec ou sans radiculalgie\u00a0: revue syst\u00e9matique et m\u00e9ta-analyse des essais comparatifs randomis\u00e9s","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2026.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique.","name":"copyright","label":"Copyright"}]}}